Ranibizumab and pegaptanib for the treatment of age-related macular degeneration

Technology appraisal guidance
Reference number: TA155
Published: 27 August 2008
Last updated: 20 May 2024

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders

Appendix A: provisional matrix of stakeholders
19 May 2014
(49.29 Kb 14 sec)

Adobe Acrobat reader required.

Adobe Acrobat reader required.

This page was last updated: 15 May 2014